156 related articles for article (PubMed ID: 7950920)
1. Proliferative response of B chronic lymphocytic leukemia lymphocytes stimulated with IL2 and soluble CD23.
Brizard A; Morel F; Lecron JC; Dreyfus B; Brizard F; Barra A; Preud'homme JL
Leuk Lymphoma; 1994 Jul; 14(3-4):311-8. PubMed ID: 7950920
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
Reinisch W; Willheim M; Hilgarth M; Gasché C; Mader R; Szepfalusi S; Steger G; Berger R; Lechner K; Boltz-Nitulescu G
J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
[TBL] [Abstract][Full Text] [Related]
4. Cell-cell interactions for CD23 expression and soluble CD23 release from peripheral lymphocytes of atopic donors.
Kicza K; Fischer A; Pfeil T; Bujanowski-Weber J; König W
Immunology; 1989 Dec; 68(4):532-9. PubMed ID: 2532620
[TBL] [Abstract][Full Text] [Related]
5. Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4.
Chomarat P; Briolay J; Banchereau J; Miossec P
Arthritis Rheum; 1993 Feb; 36(2):234-42. PubMed ID: 8431213
[TBL] [Abstract][Full Text] [Related]
6. Effects of alpha-interferon and steroids on CD23 expression and release in B-cell chronic lymphocytic leukemia.
Pozzato G; de Paoli P; Franzin F; Tulissi P; Moretti M; Basaglia G; Santini GF
Haematologica; 1994; 79(3):205-12. PubMed ID: 7926968
[TBL] [Abstract][Full Text] [Related]
7. Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4.
Hivroz C; Vallé A; Brouet JC; Banchereau J; Grillot-Courvalin C
Eur J Immunol; 1989 Jun; 19(6):1025-30. PubMed ID: 2526738
[TBL] [Abstract][Full Text] [Related]
8. In vitro effects of B cell growth and maturation factor on B-CLL lymphocytes.
Karray S; Emilie D; Galanaud P
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):275-8. PubMed ID: 3065728
[TBL] [Abstract][Full Text] [Related]
9. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
[TBL] [Abstract][Full Text] [Related]
10. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.
Molica S; Levato D; Dell'Olio M; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
Haematologica; 1996; 81(5):428-33. PubMed ID: 8952156
[TBL] [Abstract][Full Text] [Related]
11. Cytokine control of peripheral-blood CD23 expression and sCD23 release: differential regulation by IL-2 and IL-4.
Fischer A; Pfeil T; König W
Int Arch Allergy Appl Immunol; 1990; 92(4):334-42. PubMed ID: 2150667
[TBL] [Abstract][Full Text] [Related]
12. Effect of cytokines on spontaneous and allergen-induced CD23 expression, sCD23 release and Ig(E,G) synthesis from peripheral blood lymphocytes.
Pfeil T; Fischer A; Bujanowski-Weber J; Luther H; Altmeyer P; König W
Immunology; 1989 Sep; 68(1):37-44. PubMed ID: 2530155
[TBL] [Abstract][Full Text] [Related]
13. CD23 antigen regulation and signaling in chronic lymphocytic leukemia.
Fournier S; Delespesse G; Rubio M; Biron G; Sarfati M
J Clin Invest; 1992 Apr; 89(4):1312-21. PubMed ID: 1532590
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of TNF, IL-6 and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapy.
Jewell AP; Worman CP; Giles FJ; Goldstone AH
Leuk Lymphoma; 1997 Jan; 24(3-4):327-33. PubMed ID: 9156662
[TBL] [Abstract][Full Text] [Related]
15. High-affinity interleukin 2 receptors on B cell chronic lymphocytic leukemia cells are induced by phorbol myristate acetate but not by calcium ionophore.
Mitsui H; Yagura H; Tamaki T; Ikeda H; Matsumura I; Kanakura Y; Yonezawa T; Tarui S
Immunol Lett; 1991 Feb; 27(2):105-11. PubMed ID: 2026453
[TBL] [Abstract][Full Text] [Related]
16. Distinct modulation by interferon-gamma (IFN-gamma) of CD23 expression on B and T lymphocytes of atopic subjects.
Corominas M; Mestre M; Bas J; Buendia E
Clin Exp Immunol; 1998 May; 112(2):276-80. PubMed ID: 9649191
[TBL] [Abstract][Full Text] [Related]
17. [Correlational study between lymphocyte IgE markers: membrane CD23 (mCD23) and soluble CD23 (sCD23) in an atopic population].
Sabbah A; Buchmann C; Lauret MG; Drouet M
Allerg Immunol (Paris); 1993 Feb; 25(2):48-54. PubMed ID: 8466634
[TBL] [Abstract][Full Text] [Related]
18. B-cell chronic lymphocytic leukaemia populations respond stochastically to combinations of growth signals in vitro.
McManus AP; Desai ZR; Lavabre-Bertrand T
Leuk Res; 1993 Jun; 17(6):477-81. PubMed ID: 8505846
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells.
Lotz M; Ranheim E; Kipps TJ
J Exp Med; 1994 Mar; 179(3):999-1004. PubMed ID: 8113691
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.
Palacios R
Eur J Immunol; 1985 Jul; 15(7):645-51. PubMed ID: 3924633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]